Annals of Pediatric Gastroenterology and Hepatology ISPGHAN

Register      Login

VOLUME 1 , ISSUE 3 ( July-September, 2019 ) > List of Articles


Hepatoblastoma in Children: Management Strategies

Dr. G Vimal Kumar, Naresh P Shanmugam

Citation Information : Kumar DG, Shanmugam NP. Hepatoblastoma in Children: Management Strategies. Ann Pediatr Gastroenterol Hepatol 2019; 1 (3):2-7.

DOI: 10.5005/jp-journals-11009-0020

License: CC BY-NC 4.0

Published Online: 04-07-2022

Copyright Statement:  Copyright © 2019; The Author(s).


PDF Share
  1. Reynolds, P., et al., Birth characteristics and hepatoblastoma risk in young children. Cancer, 2004. 100(5): p. 1070-6.
  2. Paquette, K., et al., Cancer risk in children and young adults born preterm: A systematic review and meta-analysis. PLoS One, 2019. 14(1): p. e0210366.
  3. Zhang, G., et al., Usefulness of threedimensional(3D) simulation software in hepatectomy for pediatric hepatoblastoma. Surg Oncol, 2016. 25(3): p. 236-43.
  4. Roebuck, D.J., O. Olsen, and D. Pariente, Radiological staging in children with hepatoblastoma. Pediatr Radiol, 2006. 36(3): p. 176-82.
  5. Roebuck, D.J., et al., 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol, 2007. 37(2): p. 123-32; quiz 249-50.
  6. Czauderna, P., et al., Guidelines for surgical treatment of hepatoblastoma in the modern era--recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer, 2005. 41(7): p. 1031-6.
  7. Shanmugam, N., et al., Multidisciplinary management of hepatoblastoma in children: Experience from a developing country. Pediatr Blood Cancer, 2017. 64 (3) e26249.
  8. Ninane, J., et al., Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: a SIOP pilot study. Med Pediatr Oncol, 1991. 19(3): p. 199-203.
  9. Faraj, W., et al., Liver transplantation for hepatoblastoma. Liver Transpl, 2008. 14(11): p. 1614-9.
  10. Meyers, R.L., et al., Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation. Curr Opin Pediatr, 2014. 26(1): p. 29-36.
  11. Shanmugam, N., et al., Complete remission of refractory hepatoblastoma after liver transplantation in a child with sorafenib monotherapy: A new hope? Pediatr Blood Cancer, 2017. 64(12) e26701.
  12. Han, Y.M., et al., Effectiveness of preoperative transarterial chemoembolization in presumed inoperable hepatoblastoma. J Vasc Interv Radiol, 1999. 10(9): p. 1275-80.
  13. Lungren, M.P., et al., Role of interventional radiology in managing pediatric liver tumors: Part 1: Endovascular interventions. Pediatr Radiol, 2018. 48(4): p. 555-564.
  14. Marsh, A.M., et al., Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: stable radiographic disease with decreased AFP. Pediatr Blood Cancer, 2012. 59(5): p. 939-40.
  15. Wagner-Bohn, A., et al., Phase II study of gemcitabine in children with solid tumors of mesenchymal and embryonic origin. Anticancer Drugs, 2006. 17(7): p. 859-64.
  16. National Cancer Institute. Children's Oncology Group. Pediatric MATCH Trial.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.